<?xml version="1.0" encoding="UTF-8"?>
<collection>
<dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:invenio="http://invenio-software.org/elements/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:identifier>doi:10.1111/jgs.14885</dc:identifier><dc:language>eng</dc:language><dc:creator>Morales, Javier S.</dc:creator><dc:creator>Garatachea, Nuria</dc:creator><dc:creator>Pareja-Galeano, Helios</dc:creator><dc:title>Vitamin D for healthy aging</dc:title><dc:identifier>ART-2017-98858</dc:identifier><dc:description>Buta et al., in a longitudinal cohort study, have recently reported that women (70–79 years of age) with lower serum concentrations of 25-hydroxyvitamin D (25(OH)D) (&lt;10 ng/mL) had a 3-fold increased risk of developing frailty than those with the higher 25(OH)D (=30 ng/mL) levels. Authors found that 32.2 per 1,000 person-years in participants with 25(OH)D &lt; 10 ng/mL suffered frailty compared with an incidence of 12.9% per 1,000 person-years in those women with 25(OH)D = 30 ng/mL. The association was no longer significant after accounting cardiometabolic diseases.</dc:description><dc:date>2017</dc:date><dc:source>http://zaguan.unizar.es/record/70735</dc:source><dc:doi>10.1111/jgs.14885</dc:doi><dc:identifier>http://zaguan.unizar.es/record/70735</dc:identifier><dc:identifier>oai:zaguan.unizar.es:70735</dc:identifier><dc:relation>info:eu-repo/grantAgreement/ES/MEC/FPU14-03435</dc:relation><dc:identifier.citation>JOURNAL OF THE AMERICAN GERIATRICS SOCIETY 65, 7 (2017), 1629-1630</dc:identifier.citation><dc:rights>All rights reserved</dc:rights><dc:rights>http://www.europeana.eu/rights/rr-f/</dc:rights><dc:rights>info:eu-repo/semantics/openAccess</dc:rights></dc:dc>

</collection>